Artificial Intelligence

A new therapy for a rare brain cancer is one step closer to patients after the FDA accepted tirabrutinib for accelerated review, offering hope where few options exist.

A new managed service uses AI to fight advanced cyber threats, offering unified protection and addressing Canadian data sovereignty for North American firms.

Landmark Phase 3 trial results show psilocybin offers rapid, lasting relief for severe depression, pushing psychedelic medicine closer to the mainstream.

With 13,000 attendees and a bold expansion to Ras Al Khaimah, AIBC Eurasia 2026 highlights a major shift of tech's center of power to the East.

Allocate's 350% asset growth signals a major shift as wealth advisors embrace private markets. Discover how its AI-powered platform is making it possible.

A new health tech company has assembled a star-studded scientific board to back its AI-powered dementia prevention app. But can it deliver on its promise?

VIAVI's new ePRTC360+ meets stringent timing standards without Cesium, offering a cheaper, more resilient solution for critical infrastructure.

With a new $12M investment, Lightworks aims to help large firms move AI from pilot to production by solving the critical challenges of safety and compliance.

New long-term data shows duvakitug maintained remission in IBD patients for nearly a year, positioning it as a top contender in a new class of therapy.

A new report reveals how open source AI is fueling India's explosive market growth, creating a global talent hub, and tackling deep-seated social challenges.

As copper phone lines vanish, Ooma's new POTSTracker.com uses AI to help businesses find and replace critical legacy connections before they fail.

The new patent protects a technology that stabilizes 'undruggable' proteins, paving the way for next-gen drugs and fortifying the company's market position.

Tech titans like Micron, NVIDIA, and Applied Materials join forces in a $2.5B alliance to forge India into a global deep tech powerhouse.

A new partnership combines AI design with rapid lab testing to crack the code of complex proteins, speeding up drug discovery and opening new frontiers.

Forget simple indicators. A new breed of retail trader uses complex data, automation, and strict risk rules to gain a professional edge in the market.

A new international board of industry veterans aims to steer AML RightSource's global strategy amid rising crypto crime and complex regulations.

Oculis appoints former Cooley partner Katie Kazem as CLO, a strategic move to fortify governance ahead of pivotal data readouts for its late-stage eye drugs.

IDC MarketScape recognizes Hitachi Energy's leadership in asset management as utilities race to balance aging grids with a clean energy future.

The Israeli defense giant adds to its massive $25.2B backlog with new contracts for land systems and a future-oriented innovative defense solution.

With a bolstered cash runway from recent funding, Inventiva is all-in on its MASH drug, lanifibranor, racing against giants in a multi-billion dollar market.